We are live on ! Find out more
CODX

Co-Diagnostics
CODX

24 hedge funds and large institutions have $1.85M invested in Co-Diagnostics in 2026 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,919% more capital invested

Capital invested by funds: $91.5K → $1.85M (+$1.76M)

500% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

71% more funds holding

Funds holding: 14 → 24 (+10)

Holders
24
Holders Change
+10
Holders Change %
+71.43%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$726K
2
Jane Street
Jane Street
New York
+$275K
3
Vanguard Capital Management
Vanguard Capital Management
Pennsylvania
+$179K
4
Millennium Management
Millennium Management
New York
+$98.4K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$96.1K

Top Sellers

Rank Fund Capital Flow
1
PAG
Private Advisory Group
Washington
-$6.15K
2
JP Morgan Chase
JP Morgan Chase
New York
-$145
3
DB
Danske Bank
Denmark
-$13
4
Citigroup
Citigroup
New York
-$2

CODX Hedge Fund Activity: Q2 2026 in Review

24 of the 8,334 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q2 2026, worth a combined $1.85M — up 1,919% from $91.5K a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new CODX positions and 2 closed out — a net gain of 10 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $726K. The largest seller was Private Advisory Group, cutting an estimated $6.15K.

  • 24 institutional investors held Co-Diagnostics (CODX) as of Q2 2026, up from 14 in Q1 2026.
  • Funds reported $1.85M of Co-Diagnostics stock for Q2 2026, up 1,919% quarter-over-quarter.
  • 12 funds opened new Co-Diagnostics positions in Q2 2026 and 2 closed out, a net change of +10 holders.
  • The largest Co-Diagnostics buyer in Q2 2026 was Armistice Capital, an estimated $726K added.
  • The largest Co-Diagnostics seller in Q2 2026 was Private Advisory Group, an estimated $6.15K sold.

Based on aggregated 13F filings for Q2 2026.